+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management



Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management



Breast Cancer Research 17: 21



MicroRNAs (miRNAs) are an emerging class of gene expression modulators with relevant roles in several biological processes, including cell differentiation, development, apoptosis, and regulation of the cell cycle. Deregulation of those tiny RNA molecules has been described frequently as a major determinant for the initiation and progression of diseases, including cancer. Not only miRNAs but also the enzymes responsible for miRNA processing could be deregulated in cancer. In this review, we address the role of miRNAs in the pathogenesis of breast cancer, since there are oncogenic, tumor-suppressive, and metastatic-influencing miRNAs. Additionally, the different detection platforms and normalization strategies for miRNAs will be discussed. The major part of this review, however, will focus on the capability of miRNAs to act as diagnostic, predictive, or prognostic biomarkers. We will give an overview of their potential to correlate with response to or benefit from a given treatment and we will consider their ability to give information on prognosis in breast cancer. We will focus on miRNAs validated by more than one study or verified in independent cohorts or where results rely on preclinical as well as clinical evidence. As such, we will discuss their potential use in the personalized management of breast cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057673291

Download citation: RISBibTeXText

PMID: 25849621

DOI: 10.1186/s13058-015-0526-y


Related references

Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team. European Journal of Surgical Oncology 27(3): 229-238, 2001

MicroRNAs in colorectal cancer: Function, dysregulation and potential as novel biomarkers. Yearbook of Pathology and Laboratory Medicine 2012: 257-259, 2012

MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. European Journal of Surgical Oncology 37(8): 649-654, 2011

Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer. Non-Coding Rna 2(2), 2016

MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clinical Cancer Research 14(2): 360-365, 2008

Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes, Chromosomes and Cancer 52(4): 356-369, 2013

CDNA microarray gene expression profiles as a potential prognostic and predictive tool for an improved management of breast cancer. European Journal of Cancer 38(Supplement 3): S164, 2002

Age-associated prognostic and predictive biomarkers in patients with breast cancer. Oncology Letters 13(6): 4201-4207, 2017

The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Expert Opinion on Therapeutic Targets 16 Suppl 2: S103-S109, 2012

Prognostic and predictive potential molecular biomarkers in colon cancer. Chirurgia 106(2): 177-185, 2011

Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women. Gene 590(2): 210-219, 2017

Prognostic and predictive biomarkers in breast cancer: Past, present and future. Seminars in Cancer Biology 52(Pt 1): 56-73, 2017

The Diagnostic, Prognostic, and Predictive Potential of MicroRNA Biomarkers in Colorectal Cancer. Current Colorectal Cancer Reports 8(1): 22-31, 2012

Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer. Annals of Surgical Oncology 22 Suppl 3: S536-S544, 2016

TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancer. Tumour Biology 30(4): 200-209, 2009